Results 191 to 200 of about 28,557 (262)

Ultrasonography and Biomarkers in the Diagnostic Evaluation of Peritoneal Tuberculosis: A Case Series Analysis. [PDF]

open access: yesDiagnostics (Basel)
Putra AD   +9 more
europepmc   +1 more source

BLOOD-BASED BIOMARKERS TO IDENTIFY AND MONITOR RECURRENT ENDOMETRIAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS

open access: yes
Chitrakar A   +6 more
europepmc   +1 more source

Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis

open access: yesInternational Journal of Molecular Sciences, 2023
Currently, ovarian cancer (OC) is a target of intense biomarkers research because of its frequent late diagnosis and poor prognosis. Serum determination of Human epididymis protein 4 (HE4) is a very important early detection test. Most interestingly, HE4
Emanuela Anastasi   +2 more
exaly   +2 more sources

Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL.

Analytical Chemistry, 2023
Simultaneous detection of different disease markers is significant for clinical diagnosis. In this work, a dual-signal electrochemiluminescence (ECL) immunosensor was constructed for the simultaneous detection of carbohydrate antigen 125 (CA125) and ...
Yun Tang   +4 more
semanticscholar   +1 more source

Ovarian-Cancer Biomarker (HE4) Recognition in Serum Using Hetero TFET Biosensor

IEEE transactions on nanotechnology, 2023
Recognition of ovarian-cancer biomarker (HE4) in serum using dual-material In0.53Ga0.47As/Si hetero-structure charge-plasma-based extended gate TFET biosensor (DCE-HTFET) has been depicted in this article.
Amit Bhattacharyya, D. De, M. Chanda
semanticscholar   +1 more source

The Utility of Preoperative Serum CA125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial Cancer

Gynecologic and Obstetric Investigation, 2023
Objectives: To investigate the diagnostic performance of the serum cancer antigen 125 (CA125), human epididymis protein 4 (HE4), a combination of CA125 and HE4, and a risk of ovarian malignancy algorithm (ROMA) in the preoperative prediction of high-risk
N. Prueksaritanond   +2 more
semanticscholar   +1 more source

Diagnostic performance of CA125, HE4, ROMA, and CPH‐I in identifying primary ovarian cancer

The journal of obstetrics and gynaecology research, 2023
To evaluate the ability of carbohydrate antigen 125 (CA125), human epididymis protein 4 (HE4), risk of ovarian malignancy algorithm (ROMA), and Copenhagen Index (CPH‐I) to identify primary ovarian cancer (OC) from borderline and benign ovarian tumors ...
Hui Luo   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy